Urogen Pharma Ltd (URGN)

EBITDA

-$70.13M

TTM · Period ending: · USD

URGN logo

URGN EBITDA

Latest reported-$70.13M
URGN EBITDA (-$3.37M → -$70.13M)
High-resolution chart · PNG

URGN ebitda history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Urogen Pharma Ltd EBITDA — Annual fiscal periods (USD)
Period endingEBITDA (USD)
-135,660,000
-94,496,000
-60,352,000
-76,214,000
-107,598,000
-122,709,000
-108,154,000
-77,180,000
-19,743,000
1,011,000
-12,297,000
-4,339,000
-3,371,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.